Zain Chagla

InstitutionMcMaster University
AddressHamilton
Ontario
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 21 publications over 7 distinct years, with a maximum of 10 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chagla Z, Hota S, Khan S, Mertz D. Re: It Is Time to Address Airborne Transmission of COVID-19. Clin Infect Dis. 2021 12 06; 73(11):e3981-e3982. PMID: 32780799.
      Citations: 8     Fields:    Translation:Humans
    2. Chagla Z, Pai M. COVID-19 boosters in rich nations will delay vaccines for all. Nat Med. 2021 10; 27(10):1659-1660. PMID: 34465921.
      Citations: 2     Fields:    Translation:Humans
    3. Chagla Z. In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups. Ann Intern Med. 2021 08; 174(8):JC94. PMID: 34339222.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, Bernstein J, Bingemann T, Blumchen K, Byrne A, Bognanni A, Campbell D, Campbell R, Chagla Z, Chan ES, Chan J, Comberiati P, Dribin TE, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Grayson MH, Horner CC, Hourihane J, Katelaris CH, Kim H, Kelso JM, Lang D, Ledford D, Levin M, Lieberman J, Loh R, Mack D, Mazer B, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Oppenheimer J, Perrett KP, Ramsey A, Rank M, Robertson K, Sheikh J, Spergel JM, Stukus D, Tang MLK, Tracy JM, Turner PJ, Whalen-Browne A, Wallace D, Wang J, Waserman S, Witry JK, Worm M, Vander Leek TK, et al. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567. PMID: 34153517.
      Citations: 13     Fields:    Translation:Humans
    5. Irfan N, Chagla Z. In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant). Ann Intern Med. 2021 05; 174(5):JC50. PMID: 33939483.
      Citations: 2     Fields:    Translation:Humans
    6. Huynh A, Arnold DM, Smith JW, Moore JC, Zhang A, Chagla Z, Harvey BJ, Stacey HD, Ang JC, Clare R, Ivetic N, Chetty VT, Bowdish DME, Miller MS, Kelton JG, Nazy I. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 2021 04 16; 13(4). PMID: 33923828.
      Citations: 3     Fields:    Translation:Humans
    7. Chagla Z. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. Ann Intern Med. 2021 03; 174(3):JC29. PMID: 33646835.
      Citations: 4     Fields:    Translation:Humans
    8. Chagla Z. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 =14 d after the 2nd dose. Ann Intern Med. 2021 03; 174(3):JC28. PMID: 33646836.
      Citations: 5     Fields:    Translation:Humans
    9. Chagla Z. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 =7 days after the 2nd dose. Ann Intern Med. 2021 02; 174(2):JC15. PMID: 33524290.
      Citations: 20     Fields:    Translation:Humans
    10. Lewis K, Chaudhuri D, Alshamsi F, Carayannopoulos L, Dearness K, Chagla Z, Alhazzani W. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials. PLoS One. 2021; 16(1):e0244778. PMID: 33406138.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    11. Khan S, Tsang KK, Mertz D, Dolovich M, Tunks M, Demers C, Hassall K, Maharaj N, Margallo K, Cividino M, Chagla Z, Duong M. A regional Canadian expert consensus on recommendations for restoring exercise and pulmonary function testing in low and moderate-to-high community prevalence coronavirus disease 2019 (COVID-19) settings. Infect Control Hosp Epidemiol. 2021 12; 42(12):1535-1537. PMID: 33213540.
      Citations: 2     Fields:    Translation:Humans
    12. Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500. PMID: 33204764.
      Citations: 17     
    13. Lee TC, Butler-Laporte G, Chagla Z, McDonald EG. Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing? Clin Microbiol Infect. 2021 02; 27(2):158-159. PMID: 33007475.
      Citations: 1     Fields:    Translation:Humans
    14. Bai AD, Li XX, Alsalem M, Khan S, Smieja M, Mertz D, Chagla Z. Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study. Infect Control Hosp Epidemiol. 2020 Oct; 41(10):1233-1235. PMID: 32693864.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    15. Vannabouathong C, Devji T, Ekhtiari S, Chang Y, Phillips SA, Zhu M, Chagla Z, Main C, Bhandari M. Novel Coronavirus COVID-19: Current Evidence and Evolving Strategies. J Bone Joint Surg Am. 2020 05 06; 102(9):734-744. PMID: 32379112.
      Citations: 53     Fields:    Translation:HumansPHPublic Health
    Chagla's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (44)
    Explore
    _
    Co-Authors (138)
    Explore
    _
    Similar People (60)
    Explore
    _